Stefan Boeck (S Boeck)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 19

Top Venues

Nature

Current oncology (Toronto, Ont.)

Biomedicines

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615 (7950) (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615 (7950) (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature (2023)
Michael Guenther, Sai Agash Surendran, Michael Haas, Volker Heinemann, Michael von Bergwelt-Baildon, Jutta Engel, Jens Werner, Stefan Boeck, Steffen Ormanns
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer. British journal of cancer (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615 (7950) (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615 (7950) (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615 (7950) (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Kimberly Krueger, Zsuzsanna Mayer, Marc Kottmaier, Miriam Gerckens, Stefan Boeck, Peter Luppa, Stefan Holdenrieder
Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood. Biomedicines 10 (10) (2022)
Klara Dorman, Volker Heinemann, Sebastian Kobold, Michael von Bergwelt-Baildon, Stefan Boeck
Novel systemic treatment approaches for metastatic pancreatic cancer. Expert opinion on investigational drugs 31 (3) (2022)
Kimberly Krueger, Zsuzsanna Mayer, Miriam Gerckens, Stefan Boeck, Peter Luppa, Stefan Holdenrieder
High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood. Biomedicines 10 (10) (2022)
Michael Ruzicka, Sonja Wurm, Lars Hartwin Lindner, Martin Dreyling, Michael von Bergwelt-Baildon, Stefan Boeck, Clemens Giessen-Jung, Valeria Milani, Hans Joachim Stemmler, Marion Subklewe, Oliver Weigert, Karsten Spiekermann
Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia. Infection (2022)
Klara Dorman, Miriam Gerckens, Stephan Kruger, Kimberly Krueger, Zsuzsanna Mayer, Alexander Rupp, Danmei Zhang, Lena Weiss, C Benedikt Westphalen, Michael Haas, Michael Guenther, Steffen Ormanns, Frank Klawonn, Jens Werner, Michael von Bergwelt-Baildon, Volker Heinemann, Stefan Boeck, Stefan Holdenrieder
Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers. Journal of cancer research and clinical oncology (2022)
L Sams, S Kruger, V Heinemann, D Bararia, S Haebe, S Alig, M Haas, D Zhang, C B Westphalen, S Ormanns, P Metzger, J Werner, O Weigert, M von Bergwelt-Baildon, F Rataj, S Kobold, Stefan Boeck
Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (11) (2021)

Stefan Boeck.css-eqlu8i{font-size:small;padding-left:4px;} (S Boeck)

Publication Activity (10 Years)

Top Topics

Top Venues

Stefan Boeck (S Boeck)